Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A-Mark Precious Metals | AMRK | Mar 14, 2025 | 27.75 | +1.65 |
a.k.a Brands | AKA | Mar 14, 2025 | 11.85 | +3.67 |
A.O Smith | AOS | Mar 14, 2025 | 66.85 | +2.14 |
A10 Networks | ATEN | Mar 14, 2025 | 16.86 | +2.93 |
A2Z Cust2Mate Solutions | AZ | Mar 14, 2025 | 6.75 | +3.37 |
AA Mission Acquisition | AAM | Mar 14, 2025 | 10.23 | +0.10 |
AAA - A Rated Corporate Bond Ishares | QLTA | Mar 14, 2025 | 47.24 | -0.13 |
Aadi Bioscience | AADI | Mar 14, 2025 | 1.98 | +2.59 |
AAON | AAON | Mar 14, 2025 | 82.14 | +4.89 |
AAR | AIR | Mar 14, 2025 | 67.24 | +1.57 |
Aardvark Therapeutics | AARD | Mar 14, 2025 | 10.01 | 0.00 |
Abacus Global Management | ABL | Mar 14, 2025 | 7.62 | +1.60 |
Abbott Laboratories | ABT | Mar 14, 2025 | 126.71 | -2.45 |
AbbVie | ABBV | Mar 14, 2025 | 211.77 | +0.10 |
AbCellera Biologics | ABCL | Mar 14, 2025 | 2.52 | +5.00 |
Abeona Therapeutics | ABEO | Mar 14, 2025 | 5.29 | +0.19 |
Abercrombie & Fitch | ANF | Mar 14, 2025 | 79.79 | +5.08 |
Aberdeen Asia-Pacificome Fund | FAX | Mar 14, 2025 | 15.72 | 0.00 |
Aberdeen Australia Equity Fund | IAF | Mar 14, 2025 | 4.04 | +2.02 |
Aberdeen Emerging Markets Fund | AEF | Mar 14, 2025 | 5.13 | +0.98 |
Aberdeen Global Fund | FCO | Mar 14, 2025 | 6.04 | +0.17 |
Aberdeen Global Infrastructure | ASGI | Mar 14, 2025 | 18.10 | +1.23 |
Aberdeen Income Credit Strategies Fund | ACP | Mar 14, 2025 | 5.93 | 0.00 |
Aberdeen Income Credit Strategies Pref | ACP-A | Mar 14, 2025 | 22.14 | +0.64 |
Aberdeen Japan Equity Fund | JEQ | Mar 14, 2025 | 6.45 | +0.86 |
Abits Group | ABTS | Mar 14, 2025 | 3.16 | -4.53 |
Abivax SA - American Depositary Shares | ABVX | Mar 14, 2025 | 5.94 | +0.34 |
Able View Global | ABLV | Mar 14, 2025 | 1.02 | +2.00 |
ABM Industries | ABM | Mar 14, 2025 | 46.78 | -0.60 |
Above Food Ingredients | ABVE | Mar 14, 2025 | 0.42 | +10.53 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.